Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brew, B. J.
Right arrow Articles by Hagberg, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brew, B. J.
Right arrow Articles by Hagberg, L.
Related Collections
Right arrow HIV
Right arrow Alzheimer's disease
Right arrow HIV dementia
NEUROLOGY 2005;65:1490-1492
© 2005 American Academy of Neurology
Brief Communications

CSF amyloid ß42 and tau levels correlate with AIDS dementia complex

B. J. Brew, MBBS, MD, FRACP, L. Pemberton, BSc, K. Blennow, MD, PhD, A. Wallin, MD, PhD and L. Hagberg, MD

From the Departments of Neurology (Dr. Brew) and HIV Medicine (Dr. Brew) and Centre for Immunology (Ms. Pemberton), St. Vincent's Hospital, University of New South Wales, Sydney, Australia; Department of Clinical Neuroscience, University of Göteborg, Sahlgren's University Hospital, Mölndal, Sweden (Drs. Blennow and Wallin); and Department of Infectious Diseases, University of Goteborg, Sahlgrenska University Hospital, Goteborg, Sweden (Dr. Hagberg).

Address correspondence and reprint requests to Dr. Bruce J. Brew, Department of Neurology, Level 4 Xavier Building, Victoria St. Darlinghurst, Sydney, Australia 2010; e-mail: b.brew{at}unsw.edu.au

There is concern that AIDS dementia complex (ADC) may be complicated by Alzheimer disease (AD). Because AD presence and risk are related to CSF ß-amyloid(1-42) (Aß42), total tau (t-tau), and phosphorylated tau (p-tau), the authors examined these in ADC, AD, and controls. ADC had significantly decreased CSF Aß42 and increased t-tau and p-tau concentrations similar to AD, suggesting that ADC may be associated with AD or an AD-like process.

Supported in part by National Institutes of Health grant NS43103.

Disclosure: The authors report no conflicts of interest.

Received January 21, 2005. Accepted in final form July 20, 2005.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
D. L. Kolson
YKL-40: A Candidate Biomarker for Simian Immunodeficiency Virus and Human Immunodeficiency Virus Encephalitis?
Am. J. Pathol., July 1, 2008; 173(1): 25 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
I. E. Andras, G. Rha, W. Huang, S. Eum, P.-O. Couraud, I. A. Romero, B. Hennig, and M. Toborek
Simvastatin Protects against Amyloid {beta} and HIV-1 Tat-Induced Promoter Activities of Inflammatory Genes in Brain Endothelial Cells
Mol. Pharmacol., May 1, 2008; 73(5): 1424 - 1433.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A Mellgren, R. W. Price, L. Hagberg, L. Rosengren, B. J. Brew, and M. Gisslen
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection
Neurology, October 9, 2007; 69(15): 1536 - 1541.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.